Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples